Literature DB >> 15905602

Characterization of bacterium isolated from the sediment at coastal area of Omura Bay in Japan and several biological activities of pigment produced by this isolate.

Takuji Nakashima1, Maki Kurachi, Yoko Kato, Kenichi Yamaguchi, Tatsuya Oda.   

Abstract

Recently we discovered a bacterial strain (MS-02-063) that produces large amounts of red pigment from coastal area of Nagasaki Prefecture, Japan. Comparative 16S rDNA gene sequencing analysis revealed that strain MS-02-063 was phylogenetically closely related to gamma-proteobacterium Hahella sp. MBIC 3957 that produces prodigiosin. However, some physiological and biochemical differences between strain MS-02-063 and Hahella sp. MBIC 3957 were observed. The red pigment (RP-063) produced by this isolate was highly purified from the culture supernatant. It was speculated that RP-063 might be prodigiosin-like pigment in physical properties and biological activities such as antibacterial and cytotoxic activity. Antibacterial activity of RP-063 was examined by an agar dilution method. The results indicated that RP-063 showed antibacterial activity for specific for pathogenic gram-positive bacteria such as Staphylococcus aureus. The potency of antibacterial activity against S. aureus was nearly equal to those of tetracycline. Moreover, RP-063 showed inhibition of the superoxide generation by 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated mouse macrophage RAW 264.7 cell line. Prodigiosin members have a wide variety of biological properties, including anticancer and antimalarial, etc. Especially, potent immunosuppressive properties have been reported for prodigiosin members with the mechanism of action different from that of the other well known immunosuppressors in atopic dermatitis therapy such as cyclosporin A, FK506 and rapamycin. It is suggested that RP-063 may be able to arrest the inflammation caused by superantigens secreted from S. aureus, which colonized skin on atopic dermatitis as well as suppression of activated lymphocyte proliferation and superoxide generation from leucocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905602     DOI: 10.1111/j.1348-0421.2005.tb03744.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  9 in total

1.  Prodigiosin produced by Serratia marcescens NMCC46 as a mosquito larvicidal agent against Aedes aegypti and Anopheles stephensi.

Authors:  Chandrashekhar D Patil; Satish V Patil; Bipinchandra K Salunke; Rahul B Salunkhe
Journal:  Parasitol Res       Date:  2011-03-31       Impact factor: 2.289

2.  Antimicrobial activity of prodigiosin isolated from Serratia marcescens UFPEDA 398.

Authors:  J C Lapenda; P A Silva; M C Vicalvi; K X F R Sena; S C Nascimento
Journal:  World J Microbiol Biotechnol       Date:  2014-12-31       Impact factor: 3.312

3.  Antiproliferative, antioxidant and binding mechanism analysis of prodigiosin from newly isolated radio-resistant Streptomyces sp. strain WMA-LM31.

Authors:  Wasim Sajjad; Sajjad Ahmad; Iffat Aziz; Syed Sikander Azam; Fariha Hasan; Aamer Ali Shah
Journal:  Mol Biol Rep       Date:  2018-10-10       Impact factor: 2.316

Review 4.  How Do Quorum-Sensing Signals Mediate Algae-Bacteria Interactions?

Authors:  Lachlan Dow
Journal:  Microorganisms       Date:  2021-06-27

5.  Bioactive pigments from marine bacteria: applications and physiological roles.

Authors:  Azamjon B Soliev; Kakushi Hosokawa; Keiichi Enomoto
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-26       Impact factor: 2.629

6.  Prodigiosin production by Serratia marcescens UCP 1549 using renewable-resources as a low cost substrate.

Authors:  Helvia W Casullo de Araújo; K Fukushima; Galba M Campos Takaki
Journal:  Molecules       Date:  2010-10-08       Impact factor: 4.411

Review 7.  Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds.

Authors:  Ramanathan Srinivasan; Arunachalam Kannappan; Chunlei Shi; Xiangmin Lin
Journal:  Mar Drugs       Date:  2021-09-23       Impact factor: 5.118

8.  Antibacterial and anti-inflammatory activities of marine Brevibacterium sp.

Authors:  Vennam Srilekha; Gudikandula Krishna; Vutukuru Seshasrinivas; Maringanti Alha Singara Charya
Journal:  Res Pharm Sci       Date:  2017-08

Review 9.  Production and Potential Applications of Bioconversion of Chitin and Protein-Containing Fishery Byproducts into Prodigiosin: A Review.

Authors:  San-Lang Wang; Van Bon Nguyen; Chien Thang Doan; Thi Ngoc Tran; Minh Trung Nguyen; Anh Dzung Nguyen
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.